Novel therapeutical approaches based on neurobiological and genetic strategies for diabetic polyneuropathy - A review
Neuropathy is among the most often reported consequences of diabetes and the biggest cause of morbidity and mortality in people suffering from this life-long disease. Although different therapeutic methods are available for diabetic neuropathy, it is still the leading cause of limb amputations, and...
Gespeichert in:
Veröffentlicht in: | Diabetes & metabolic syndrome clinical research & reviews 2023-11, Vol.17 (11), p.102901-102901, Article 102901 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 102901 |
---|---|
container_issue | 11 |
container_start_page | 102901 |
container_title | Diabetes & metabolic syndrome clinical research & reviews |
container_volume | 17 |
creator | Sher, Emina Karahmet Džidić-Krivić, Amina Karahmet, Alma Beća-Zećo, Merima Farhat, Esma Karahmet Softić, Adaleta Sher, Farooq |
description | Neuropathy is among the most often reported consequences of diabetes and the biggest cause of morbidity and mortality in people suffering from this life-long disease. Although different therapeutic methods are available for diabetic neuropathy, it is still the leading cause of limb amputations, and it significantly decreases patients' quality of life.
This study investigates potential novel therapeutic options that could ameliorate symptoms of DN.
Research and review papers from the last 10 years were taken into consideration.
There are various traditional drugs and non-pharmacological methods used to treat this health condition. However, the research in the area of pathogenic-oriented drugs in the treatment of DN showed no recent breakthroughs, mostly due to the limited evidence about their effectiveness and safety obtained through clinical trials. Consequently, there is an urgent demand for the development of novel therapeutic options for diabetic neuropathy.
Some of the latest novel diagnostic methods for diagnosing diabetic neuropathy are discussed as well as the new therapeutic approaches, such as the fusion of neuronal cells with stem cells, targeting gene delivery and novel drugs. |
doi_str_mv | 10.1016/j.dsx.2023.102901 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2889241023</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2889241023</sourcerecordid><originalsourceid>FETCH-LOGICAL-c344t-ad29f0d1228023894401479dd57f63f837cf0b3b461bd3585c6d73222883dda83</originalsourceid><addsrcrecordid>eNo9kMtOwzAQRS0EoqXwAWyQl2xS_EpjL6uKl1TBBtaWE0_aVGkc7KTQv8dtCqt56NyR5iB0S8mUEjp72Ext-JkywnicmSL0DI2pzGRCOBfnx54mgjA6QlchbAhJU8XUJRrxTKWUKDlG_ZvbQY27NXjTQt9VhamxaVvvTLGGgHMTwGLX4AZ67_LK1W41MI3FK2ggJnDovOlgVUW-dB7byuTHfevq_THXmm69xwmeYw-7Cr6v0UVp6gA3pzpBn0-PH4uXZPn-_LqYL5OCC9ElxjJVEksZk_FHqYQgVGTK2jQrZ7yUPCtKkvNczGhueSrTYmYzziIuubVG8gm6H-7Gf756CJ3eVqGAujYNuD7oCComojseUTqghXcheCh166ut8XtNiT7Y1hsdbeuDbT3Yjpm70_k-34L9T_zp5b-J4H0Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2889241023</pqid></control><display><type>article</type><title>Novel therapeutical approaches based on neurobiological and genetic strategies for diabetic polyneuropathy - A review</title><source>Access via ScienceDirect (Elsevier)</source><creator>Sher, Emina Karahmet ; Džidić-Krivić, Amina ; Karahmet, Alma ; Beća-Zećo, Merima ; Farhat, Esma Karahmet ; Softić, Adaleta ; Sher, Farooq</creator><creatorcontrib>Sher, Emina Karahmet ; Džidić-Krivić, Amina ; Karahmet, Alma ; Beća-Zećo, Merima ; Farhat, Esma Karahmet ; Softić, Adaleta ; Sher, Farooq</creatorcontrib><description>Neuropathy is among the most often reported consequences of diabetes and the biggest cause of morbidity and mortality in people suffering from this life-long disease. Although different therapeutic methods are available for diabetic neuropathy, it is still the leading cause of limb amputations, and it significantly decreases patients' quality of life.
This study investigates potential novel therapeutic options that could ameliorate symptoms of DN.
Research and review papers from the last 10 years were taken into consideration.
There are various traditional drugs and non-pharmacological methods used to treat this health condition. However, the research in the area of pathogenic-oriented drugs in the treatment of DN showed no recent breakthroughs, mostly due to the limited evidence about their effectiveness and safety obtained through clinical trials. Consequently, there is an urgent demand for the development of novel therapeutic options for diabetic neuropathy.
Some of the latest novel diagnostic methods for diagnosing diabetic neuropathy are discussed as well as the new therapeutic approaches, such as the fusion of neuronal cells with stem cells, targeting gene delivery and novel drugs.</description><identifier>ISSN: 1871-4021</identifier><identifier>EISSN: 1878-0334</identifier><identifier>DOI: 10.1016/j.dsx.2023.102901</identifier><identifier>PMID: 37951098</identifier><language>eng</language><publisher>Netherlands</publisher><ispartof>Diabetes & metabolic syndrome clinical research & reviews, 2023-11, Vol.17 (11), p.102901-102901, Article 102901</ispartof><rights>Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c344t-ad29f0d1228023894401479dd57f63f837cf0b3b461bd3585c6d73222883dda83</citedby><cites>FETCH-LOGICAL-c344t-ad29f0d1228023894401479dd57f63f837cf0b3b461bd3585c6d73222883dda83</cites><orcidid>0000-0003-2890-5912</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37951098$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sher, Emina Karahmet</creatorcontrib><creatorcontrib>Džidić-Krivić, Amina</creatorcontrib><creatorcontrib>Karahmet, Alma</creatorcontrib><creatorcontrib>Beća-Zećo, Merima</creatorcontrib><creatorcontrib>Farhat, Esma Karahmet</creatorcontrib><creatorcontrib>Softić, Adaleta</creatorcontrib><creatorcontrib>Sher, Farooq</creatorcontrib><title>Novel therapeutical approaches based on neurobiological and genetic strategies for diabetic polyneuropathy - A review</title><title>Diabetes & metabolic syndrome clinical research & reviews</title><addtitle>Diabetes Metab Syndr</addtitle><description>Neuropathy is among the most often reported consequences of diabetes and the biggest cause of morbidity and mortality in people suffering from this life-long disease. Although different therapeutic methods are available for diabetic neuropathy, it is still the leading cause of limb amputations, and it significantly decreases patients' quality of life.
This study investigates potential novel therapeutic options that could ameliorate symptoms of DN.
Research and review papers from the last 10 years were taken into consideration.
There are various traditional drugs and non-pharmacological methods used to treat this health condition. However, the research in the area of pathogenic-oriented drugs in the treatment of DN showed no recent breakthroughs, mostly due to the limited evidence about their effectiveness and safety obtained through clinical trials. Consequently, there is an urgent demand for the development of novel therapeutic options for diabetic neuropathy.
Some of the latest novel diagnostic methods for diagnosing diabetic neuropathy are discussed as well as the new therapeutic approaches, such as the fusion of neuronal cells with stem cells, targeting gene delivery and novel drugs.</description><issn>1871-4021</issn><issn>1878-0334</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNo9kMtOwzAQRS0EoqXwAWyQl2xS_EpjL6uKl1TBBtaWE0_aVGkc7KTQv8dtCqt56NyR5iB0S8mUEjp72Ext-JkywnicmSL0DI2pzGRCOBfnx54mgjA6QlchbAhJU8XUJRrxTKWUKDlG_ZvbQY27NXjTQt9VhamxaVvvTLGGgHMTwGLX4AZ67_LK1W41MI3FK2ggJnDovOlgVUW-dB7byuTHfevq_THXmm69xwmeYw-7Cr6v0UVp6gA3pzpBn0-PH4uXZPn-_LqYL5OCC9ElxjJVEksZk_FHqYQgVGTK2jQrZ7yUPCtKkvNczGhueSrTYmYzziIuubVG8gm6H-7Gf756CJ3eVqGAujYNuD7oCComojseUTqghXcheCh166ut8XtNiT7Y1hsdbeuDbT3Yjpm70_k-34L9T_zp5b-J4H0Q</recordid><startdate>202311</startdate><enddate>202311</enddate><creator>Sher, Emina Karahmet</creator><creator>Džidić-Krivić, Amina</creator><creator>Karahmet, Alma</creator><creator>Beća-Zećo, Merima</creator><creator>Farhat, Esma Karahmet</creator><creator>Softić, Adaleta</creator><creator>Sher, Farooq</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2890-5912</orcidid></search><sort><creationdate>202311</creationdate><title>Novel therapeutical approaches based on neurobiological and genetic strategies for diabetic polyneuropathy - A review</title><author>Sher, Emina Karahmet ; Džidić-Krivić, Amina ; Karahmet, Alma ; Beća-Zećo, Merima ; Farhat, Esma Karahmet ; Softić, Adaleta ; Sher, Farooq</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c344t-ad29f0d1228023894401479dd57f63f837cf0b3b461bd3585c6d73222883dda83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sher, Emina Karahmet</creatorcontrib><creatorcontrib>Džidić-Krivić, Amina</creatorcontrib><creatorcontrib>Karahmet, Alma</creatorcontrib><creatorcontrib>Beća-Zećo, Merima</creatorcontrib><creatorcontrib>Farhat, Esma Karahmet</creatorcontrib><creatorcontrib>Softić, Adaleta</creatorcontrib><creatorcontrib>Sher, Farooq</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes & metabolic syndrome clinical research & reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sher, Emina Karahmet</au><au>Džidić-Krivić, Amina</au><au>Karahmet, Alma</au><au>Beća-Zećo, Merima</au><au>Farhat, Esma Karahmet</au><au>Softić, Adaleta</au><au>Sher, Farooq</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel therapeutical approaches based on neurobiological and genetic strategies for diabetic polyneuropathy - A review</atitle><jtitle>Diabetes & metabolic syndrome clinical research & reviews</jtitle><addtitle>Diabetes Metab Syndr</addtitle><date>2023-11</date><risdate>2023</risdate><volume>17</volume><issue>11</issue><spage>102901</spage><epage>102901</epage><pages>102901-102901</pages><artnum>102901</artnum><issn>1871-4021</issn><eissn>1878-0334</eissn><abstract>Neuropathy is among the most often reported consequences of diabetes and the biggest cause of morbidity and mortality in people suffering from this life-long disease. Although different therapeutic methods are available for diabetic neuropathy, it is still the leading cause of limb amputations, and it significantly decreases patients' quality of life.
This study investigates potential novel therapeutic options that could ameliorate symptoms of DN.
Research and review papers from the last 10 years were taken into consideration.
There are various traditional drugs and non-pharmacological methods used to treat this health condition. However, the research in the area of pathogenic-oriented drugs in the treatment of DN showed no recent breakthroughs, mostly due to the limited evidence about their effectiveness and safety obtained through clinical trials. Consequently, there is an urgent demand for the development of novel therapeutic options for diabetic neuropathy.
Some of the latest novel diagnostic methods for diagnosing diabetic neuropathy are discussed as well as the new therapeutic approaches, such as the fusion of neuronal cells with stem cells, targeting gene delivery and novel drugs.</abstract><cop>Netherlands</cop><pmid>37951098</pmid><doi>10.1016/j.dsx.2023.102901</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-2890-5912</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1871-4021 |
ispartof | Diabetes & metabolic syndrome clinical research & reviews, 2023-11, Vol.17 (11), p.102901-102901, Article 102901 |
issn | 1871-4021 1878-0334 |
language | eng |
recordid | cdi_proquest_miscellaneous_2889241023 |
source | Access via ScienceDirect (Elsevier) |
title | Novel therapeutical approaches based on neurobiological and genetic strategies for diabetic polyneuropathy - A review |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T00%3A33%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20therapeutical%20approaches%20based%20on%20neurobiological%20and%20genetic%20strategies%20for%20diabetic%20polyneuropathy%20-%20A%20review&rft.jtitle=Diabetes%20&%20metabolic%20syndrome%20clinical%20research%20&%20reviews&rft.au=Sher,%20Emina%20Karahmet&rft.date=2023-11&rft.volume=17&rft.issue=11&rft.spage=102901&rft.epage=102901&rft.pages=102901-102901&rft.artnum=102901&rft.issn=1871-4021&rft.eissn=1878-0334&rft_id=info:doi/10.1016/j.dsx.2023.102901&rft_dat=%3Cproquest_cross%3E2889241023%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2889241023&rft_id=info:pmid/37951098&rfr_iscdi=true |